
In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized …
2019年1月9日 · By proof-of-principle experiments, we here fused CD9 with HuR, an RNA binding protein interacting with miR-155 with a relatively high affinity. In the exosome packaging cells, …
人工改造的外泌体,高效递送RNA,并有效治疗疾病模型 - 知乎
该研究通过构建融合cd9-hur蛋白,设计了一种新型外泌体,具有很强的富集特定rnas的能力,有效递送rna进入细胞,体内体外实验均有效靶向靶基因,并对肝病小鼠模型有效治疗,这一策略 …
基因编辑|深度了解CRISPR/Cas9技术_蛋白_tracrRNA_系统
2023年10月17日 · 在sgRNA的引导下,Cas9蛋白可以实现对目的基因的定向切割,使DNA产生双链断裂 (DSB),经过细胞自主性的非同源末端连接 (NHEJ)或同源重组 (HR)进行修复,对靶基 …
包载 miR-155 的外泌体被CD9-HuR 融合蛋白修饰 - 搜狐
6 天之前 · CD9-HuR 融合蛋白修饰的外泌体包载 miR-155 能够通过 HuR 蛋白与 miR-155 的特异性结合,增强外泌体对 miR-155 的装载和递送效率,外泌体具有天然的生物相容性和低免疫 …
外泌体作为药物传递系统的前景及挑战 - PMC
修饰后的细胞表达融合蛋白 hur-cd9,由于 hur 对 rna 具有超高亲和力,且 cd9 是外泌体的跨膜蛋白,因此母细胞产生的外泌体能主动增加 rna 的装载量。 不同装载方法具有不同的装载效 …
In this study, we fused CD9 with HuR (human antigen R), an RNA binding protein that interacts with AREs in the target RNA with a relatively high a nity,20 ffi and explored its e in exosome …
In vitro and in vivo RNA inhibition by CD9-HuR functionalized …
By proof-of-principle experiments, we herefused CD9 with HuR, an RNA binding protein interacting with miR-155with a relatively high affinity. In the exosome packaging cells, thefused …
In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized
By proof-of-principle experiments, we here fused CD9 with HuR, an RNA binding protein interacting with miR-155 with a relatively high affinity. In the exosome packaging cells, the …
In vitro and in vivo RNA inhibition by CD9-HuR ... - ResearchGate
2018年12月5日 · By proof-of-principle experiments, we here fused CD9 with HuR, an RNA binding protein interacts with miR-155 with a relatively high affinity. In the exosome packaging …
In Vitro and in Vivo RNA Inhibition by CD9-HuR ... - ScienceGate
In vitro analysis of virus-associated RNA I (VAI RNA): inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and …
- 某些结果已被删除